In agreement with these findings, the TH-CS treatment significantly reduced the levels of TNF-α and IL-6 in the NAFLD mice, suggesting that the TH-CS effectively protected liver cells from the inflammatory effects caused by HFD intake. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.